OnKure Therapeutics, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
OnKure Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2020 to Q3 2024.
  • OnKure Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $826K, a 42.2% decline year-over-year.
  • OnKure Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $4.21M, a 15.9% decline year-over-year.
  • OnKure Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $5.11M, a 18.3% increase from 2022.
  • OnKure Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $4.32M, a 11% increase from 2021.
  • OnKure Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $3.89M, a 890% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $4.21M $826K -$603K -42.2% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $4.82M $989K -$218K -18.1% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $5.03M $1.08M -$79K -6.83% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $5.11M $1.32M +$102K +8.38% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 $5.01M $1.43M +$439K +44.3% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $4.57M $1.21M +$201K +20% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 $4.37M $1.16M +$50K +4.52% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 $4.32M $1.22M -$204K -14.4% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 $4.52M $990K -$155K -13.5% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $4.68M $1.01M +$152K +17.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $4.53M $1.11M +$636K +135% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $3.89M $1.42M +$1.29M +1002% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-27
Q3 2021 $2.6M $1.15M +$1.06M +1263% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $1.54M $854K +$766K +870% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $772K $471K +$379K +412% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $393K $129K Oct 1, 2020 Dec 31, 2020 10-K 2022-03-23
Q3 2020 $84K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 $88K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-11
Q1 2020 $92K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.